Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDowning Strate. Regulatory News (DSM)

  • This share is currently suspended. It was suspended at a price of 4.05
  • There is currently no data for DSM

Statement re Requisitioned General Meeting

25 Jul 2024 07:00

RNS Number : 7226X
Downing Strategic Micro-Cap IT PLC
25 July 2024
 

Downing Strategic Micro-Cap Investment Trust plc (the "Company")

LEI Number: 213800QMYPUW4POFFX69

Board Receives Support From Independent Advisors

 

 

Following the receipt of a request to requisition a general meeting of the Company (the "Requisition") from Vidacos Nominees Limited, acting as nominee of Milkwood Capital Limited ("Milkwood"), the resolutions put forward at the General Meeting on 5 August 2024 have been assessed by a key leading independent proxy advisory agency working in the financial markets.

The assessment of this globally respected advisor is to vote Against each of the Requisitioned Resolutions, which is in line with the board's unanimous recommendation.

As stated before the Board considers that Milkwood's decision to lodge the Requisition is wholly self-interested and disruptive when the Board and the Investment Manager are focused on returning cash to shareholders pursuant to the shareholder approved managed wind-down of the Company. 

Shareholders are reminded, if voting by proxy, that the latest time and date for lodging proxy forms or submitting proxy instructions online in connection with the requisitioned general meeting is 10.00 a.m. on 1 August 2024, however, intermediaries will have set earlier deadlines for underlying holders to provide them with voting instructions. The record date and time for the purposes of being entitled to vote at the requisitioned general meeting is 6.00 p.m. on 1 August 2024, and the meeting will be held on 5 August 2024 at 10.00 a.m.

Hugh Aldous, chairman of the Company, commented: "It is clear that the leading governance advisors, who are trusted by major fund managers around the world, are in agreement that the proposals would put the Company under the leadership of directors who are not independent and will not necessarily represent the interests of all shareholders. I am pleased that they agree with the Board in rejecting these self-interested proposals."

If you are in any doubt about what action to take in respect of matters in connection with your investment in DSM (including whether to vote or not, or how to vote) you should consult your independent professional adviser authorised pursuant to the Financial Services and Markets Act 2000"

 

For further information, please contact:

Chairman

Hugh Aldous

Tel: 020 7416 7780

 

Dickson Minto Advisers LLP

Douglas Armstrong

Tel: 020 7649 6823

 

Media Contacts - Garfield Advisory

Andrew Garfield

Tel: 07974 982337

Jason Nisse

Tel: 07769 688618

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSEAFMLELSEFW
Date   Source Headline
16th Jul 20245:05 pmRNSHolding(s) in Company
16th Jul 20249:44 amRNSNet Asset Value(s)
15th Jul 202410:09 amRNSNet Asset Value(s)
12th Jul 20244:14 pmRNSHolding(s) in Company
12th Jul 202412:38 pmRNSNet Asset Value(s)
11th Jul 202410:29 amRNSNet Asset Value(s)
10th Jul 202410:38 amRNSNet Asset Value(s)
9th Jul 202412:13 pmRNSNet Asset Value(s)
8th Jul 202412:28 pmRNSNet Asset Value(s)
8th Jul 20247:00 amRNSCircular & Notice of Requisitioned General Meeting
5th Jul 202411:21 amRNSNet Asset Value(s)
4th Jul 202411:47 amRNSNet Asset Value(s)
3rd Jul 202410:40 amRNSNet Asset Value(s)
2nd Jul 202412:43 pmRNSNet Asset Value(s)
1st Jul 20241:58 pmRNSNet Asset Value(s)
28th Jun 20241:02 pmRNSNet Asset Value(s)
27th Jun 202411:00 amRNSNet Asset Value(s)
26th Jun 202412:03 pmRNSNet Asset Value(s)
25th Jun 202411:43 amRNSNet Asset Value(s)
24th Jun 20241:11 pmRNSNet Asset Value(s)
21st Jun 202412:11 pmRNSNet Asset Value(s)
20th Jun 202410:00 amRNSNet Asset Value(s)
19th Jun 202411:14 amRNSNet Asset Value(s)
18th Jun 20244:19 pmRNSStatement re receipt of requisition notice
18th Jun 20241:02 pmRNSDividend Declaration
18th Jun 202411:01 amRNSNet Asset Value(s)
17th Jun 202410:40 amRNSNet Asset Value(s)
14th Jun 202411:55 amRNSNet Asset Value(s)
13th Jun 202411:21 amRNSNet Asset Value(s)
12th Jun 202411:59 amRNSNet Asset Value(s)
11th Jun 202411:40 amRNSNet Asset Value(s)
10th Jun 202411:57 amRNSNet Asset Value(s)
7th Jun 202411:20 amRNSNet Asset Value(s)
6th Jun 20242:36 pmRNSNet Asset Value(s)
6th Jun 20247:00 amRNSFinal Results
5th Jun 202412:40 pmRNSNet Asset Value(s)
4th Jun 202411:48 amRNSNet Asset Value(s)
3rd Jun 202412:15 pmRNSNet Asset Value(s)
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20241:13 pmRNSNet Asset Value(s)
30th May 20245:02 pmRNSPortfolio Update and intention to pay a dividend
30th May 202412:56 pmRNSNet Asset Value(s)
29th May 202412:23 pmRNSNet Asset Value(s)
28th May 20241:20 pmRNSNet Asset Value(s)
28th May 202411:54 amRNSTransaction in Own Shares
28th May 20247:00 amRNSDividend Declaration
24th May 202410:31 amRNSNet Asset Value(s)
23rd May 202411:41 amRNSNet Asset Value(s)
22nd May 202410:56 amRNSNet Asset Value(s)
21st May 202410:51 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.